Can non-fundable trials be conducted anyway? The case for open, randomised, actively controlled trials in rheumatology.
作者信息
Giannini E H
机构信息
William S Rowe Division of Rheumatology, Children's Hospital Medical Center, University of Cincinnati College of Medicine, USA.
出版信息
Ann Rheum Dis. 1998 Mar;57(3):128-30. doi: 10.1136/ard.57.3.128.
Abstract
摘要
相似文献
1
Can non-fundable trials be conducted anyway? The case for open, randomised, actively controlled trials in rheumatology.无论如何，是否可以进行无法获得资金支持的试验？关于风湿病领域开放、随机、积极对照试验的情况。
Ann Rheum Dis. 1998 Mar;57(3):128-30. doi: 10.1136/ard.57.3.128.
2
Trend in methodological quality of randomised clinical trials in low back pain.腰痛随机临床试验的方法学质量趋势
Best Pract Res Clin Rheumatol. 2005 Aug;19(4):529-39. doi: 10.1016/j.berh.2005.02.001.
3
Where's the evidence? Putting clinical science into pediatric rheumatology.
J Rheumatol. 1996 Sep;23(9):1502-4.
4
Entertaining patients and dazzling reviewers.取悦患者并让评审者眼前一亮。
J Rheumatol. 2007 May;34(5):908-11.
5
Use of statistical analysis in open extension studies.开放扩展研究中统计分析的应用。
J Rheumatol. 2006 Feb;33(2):437; author reply 437-8.
6
Clinical trials in rheumatology.风湿病学中的临床试验。
Curr Opin Rheumatol. 1993 Mar;5(2):146-52. doi: 10.1097/00002281-199305020-00004.
7
Methodology for clinical trials in rheumatology: logical foundations.风湿病学临床试验方法：逻辑基础
J Rheumatol. 1997 Oct;24(10):1861-5.
8
What are open-label extension studies for?
J Rheumatol. 2006 Apr;33(4):642-3.
9
How the type of risk reduction influences required sample sizes in randomised clinical trials.风险降低类型如何影响随机临床试验中所需的样本量。
Ann Rheum Dis. 2004 Nov;63(11):1368-71. doi: 10.1136/ard.2003.014035. Epub 2004 Jul 1.
10
Longitudinal studies in rheumatology: some guidance for analysis.风湿病学中的纵向研究：分析指南
Bull NYU Hosp Jt Dis. 2012;70(2):65-72.
本文引用的文献
1
The promise and problems of meta-analysis.元分析的前景与问题。
N Engl J Med. 1997 Aug 21;337(8):559-61. doi: 10.1056/NEJM199708213370810.
2
Discrepancies between meta-analyses and subsequent large randomized, controlled trials.荟萃分析与随后的大型随机对照试验之间的差异。
N Engl J Med. 1997 Aug 21;337(8):536-42. doi: 10.1056/NEJM199708213370806.
3
Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute.
J Clin Oncol. 1997 Jul;15(7):2736-43. doi: 10.1200/JCO.1997.15.7.2736.
4
Preliminary definition of improvement in juvenile arthritis.青少年关节炎改善的初步定义。
Arthritis Rheum. 1997 Jul;40(7):1202-9. doi: 10.1002/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R.
5
Combination DMARD therapy for rheumatoid arthritis: a step closer to the goal.类风湿关节炎的联合改善病情抗风湿药治疗：向目标又迈进了一步。
Ann Rheum Dis. 1996 Nov;55(11):781-3. doi: 10.1136/ard.55.11.781.
6
Where's the evidence? Putting clinical science into pediatric rheumatology.
J Rheumatol. 1996 Sep;23(9):1502-4.
7
Improving the quality of reporting of randomized controlled trials. The CONSORT statement.提高随机对照试验报告的质量。CONSORT声明。
JAMA. 1996 Aug 28;276(8):637-9. doi: 10.1001/jama.276.8.637.
8
9
Children and cancer. A perspective from the Cancer Therapy Evaluation Program, National Cancer Institute.儿童与癌症。美国国立癌症研究所癌症治疗评估项目的观点。
Cancer. 1993 May 15;71(10 Suppl):3422-8. doi: 10.1002/1097-0142(19930515)71:10+<3422::aid-cncr2820711748>3.0.co;2-4.
10
Users' guides to the medical literature.医学文献用户指南
JAMA. 1993 Nov 3;270(17):2096-7.
Zotero 插件